Application of the 2015/2016 EULAR recommendations for cardiovascular risk in daily practice: data from an observational study

Claire Immediato Daïen; Amandine Tubery; Guilhem du Cailar; Thibault Mura; François Roubille; Jacques Morel; Jean Bousquet; Pierre Fesler; Bernard Combe

doi:10.1136/annrheumdis-2017-211074

Application of the 2015/2016 EULAR recommendations for cardiovascular risk in daily practice: data from an observational study

Ann Rheum Dis. 2018 Apr;77(4):625-626. doi: 10.1136/annrheumdis-2017-211074. Epub 2017 May 6.

Authors

Claire Immediato Daïen^{1

2}, Amandine Tubery¹, Guilhem du Cailar³, Thibault Mura⁴, François Roubille⁵, Jacques Morel^{1

2}, Jean Bousquet⁶, Pierre Fesler³, Bernard Combe^{1

2}

Affiliations

¹ Department of Rheumatology, Lapeyronie Hospital and Montpellier University, Montpellier, France.
² Institute of Molecular Genetics, Montpellier, France.
³ Internal Medicine and Hypertension, Lapeyronie Hospital and Montpellier University, Montpellier, France.
⁴ Department of Medical Information, Montpellier University, Montpellier, France.
⁵ Department of Cardiology, Arnaud de Villeneuve Hospital and Montpellier University, Montpellier, France.
⁶ University Hospital, Montpellier, France.

PMID: 28478400
DOI: 10.1136/annrheumdis-2017-211074

No abstract available

Keywords: Cardiovascular risk; EULAR; European Innovation Partnership on Active and Healthy Ageing; chronic rheumatic disease; multimorbidity; recommendations.

Publication types

Letter
Observational Study
Research Support, Non-U.S. Gov't

MeSH terms

Aged
Arthritis, Rheumatoid / complications*
Cardiovascular Diseases / etiology*
Cardiovascular Diseases / prevention & control
Carotid Arteries / diagnostic imaging
Cholesterol, HDL / blood
Cholesterol, LDL / blood
Female
Humans
Hydroxymethylglutaryl-CoA Reductase Inhibitors / therapeutic use
Male
Middle Aged
Practice Guidelines as Topic*
Prospective Studies
Risk Assessment / methods*
Risk Assessment / standards*
Risk Factors
Ultrasonography / methods

Substances

Cholesterol, HDL
Cholesterol, LDL
Hydroxymethylglutaryl-CoA Reductase Inhibitors